Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03775213 · ClinicalTrials.gov registry record · NA
Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 322
- Enrollment target
NCT03775213 is a NA study that has completed, run by Duke University. The registered enrollment target is 322 participants.
The verdict
NCT03775213, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 322 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate a decision support tool for patients diagnosed with ductal carcinoma in situ (DCIS).
Interventions
- BEHAVIORAL Decision Support Tool with Active Monitoring
- BEHAVIORAL Decision Support Tool without Active Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 322 participants |
| Start Date | 2021-10-12 |
| Est. Completion | 2022-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03775213
The ClinicalTrials.gov registry entry for NCT03775213 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 322 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Decision Support Tool with Active Monitoring is the first listed.
NCT03775213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03775213 about?
NCT03775213 is a clinical study titled "Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)". The purpose of this research study is to evaluate a decision support tool for patients diagnosed with ductal carcinoma in situ (DCIS).
What is the current status of trial NCT03775213?
This trial is currently completed. It is a NA study. The enrollment target is 322 participants. The study started on 2021-10-12. Estimated completion is 2022-01-31.
What interventions are being tested in trial NCT03775213?
The interventions under investigation include: Decision Support Tool with Active Monitoring (BEHAVIORAL), Decision Support Tool without Active Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT03775213?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.